Search
for
Sort by
Research 211–240 of 422
- What’s new in the treatment of hair loss?
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Can gut flora changes be new biomarkers for depression?
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas
- Supplementary Material for: Finasteride and Suicide: A Postmarketing Case Series
- A proposed etiopathology of persistent dysfunctions emerging from use and discontinuation of 5-alpha reductase inhibitors: sequelae of drug-mediated microvasculopathy
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- The connection of 5-alpha reductase inhibitors to the development of depression
- Androgenetic alopecia: An update
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Finasteride
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Long-term Treatment with a 5-Alpha-Reductase Inhibitor AlleviatesDepression-like Behavior in Obese Male Rats
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Role of oral minoxidil in the treatment of androgenetic alopecia
- Anti-SARS-CoV-2 Action of 5α-Reductase Inhibitors May Be Mediated by Dehydroepiandrosterone. Letter.
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- The Effect of Finasteride on the Secretion of Testosterone, DHT, LH, FSH and Tissue Factors in the Testis of NMRI Mice: